UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations

Journal of antimicrobial chemotherapy, 2010-04, Vol.65 (suppl-2), p.ii5-ii10

Davies, Brian E

2010

Volltextzugriff (PDF)

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study

Journal of theoretical biology, 2011-01, Vol.269 (1), p.234-244

2011

Volltextzugriff (PDF)

Exploring cell tropism as a possible contributor to influenza infection severity

PloS one, 2010-11, Vol.5 (11), p.e13811-e13811

2010

Volltextzugriff (PDF)

Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir

The Journal of infectious diseases, 2011-04, Vol.203 (7), p.937-942

2011

Volltextzugriff (PDF)

Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B-Cell Levels Do Not Correlate With Clinical Response

Journal of clinical pharmacology, 2007-09, Vol.47 (9), p.1119-1128

2007

Volltextzugriff (PDF)

Absence of Adverse Effects of Oseltamivir on Sleep: A Double‐Blind, Randomized Study in Healthy Volunteers in Japan

Basic & clinical pharmacology & toxicology, 2011-10, Vol.109 (4), p.309-314

2011

Volltextzugriff (PDF)

A PBPK model describing a xenobiotic with a short PK event scale

Journal of pharmacokinetics and pharmacodynamics, 2015-08, Vol.42 (4), p.409-416

2015

Volltextzugriff (PDF)

Effect of Impaired Renal Function on the Pharmacokinetics of Tomopenem (RO4908463/CS-023), a Novel Carbapenem

Antimicrobial Agents and Chemotherapy, 2008-07, Vol.52 (7), p.2360-2366

2008

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants

Clinical pharmacokinetics, 2016-02, Vol.55 (2), p.225-236

2016

Volltextzugriff (PDF)

Effect of oseltamivir treatment on anticoagulation: a cross‐over study in warfarinized patients

British journal of clinical pharmacology, 2010-12, Vol.70 (6), p.834-843

2010

Volltextzugriff (PDF)

Protective values for soil lead with respect to child health: a critique of UK guidelines

Environmental geochemistry and health, 2008-12, Vol.30 (6), p.639-646

Davies, Brian E

2008

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

Journal of clinical pharmacology, 2012-08, Vol.52 (8), p.1255-1264

2012

Volltextzugriff (PDF)

Lack of age and gender effects on single‐dose pharmacokinetics of tomopenem (RO4908463/CS‐023), a novel carbapenem

British journal of clinical pharmacology, 2009-04, Vol.67 (4), p.469-472

2009

Volltextzugriff (PDF)

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency

American journal of kidney diseases, 2000-12, Vol.36 (6), p.1207-1212

2000

Volltextzugriff (PDF)

Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment

Investigative radiology, 1999-07, Vol.34 (7), p.443-443

1999

Volltextzugriff (PDF)

Evaluation of water quality of the Qaraaoun Reservoir, Lebanon: Suitability for multipurpose usage

Environmental monitoring and assessment, 2002-07, Vol.77 (1), p.11-30

2002

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Gadobenate Dimeglumine (Multihance) in Subjects With Impaired Liver Function

Investigative radiology, 2002-05, Vol.37 (5), p.299-308

2002

Volltextzugriff (PDF)

Effect of R667, a Novel Emphysema Agent, on the Pharmacokinetics of Midazolam in Healthy Men

Journal of clinical pharmacology, 2006-02, Vol.46 (2), p.222-228

2006

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1768-1776

1995

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks

Cancer chemotherapy and pharmacology, 1995-01, Vol.35 (3), p.237-245

1995

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase ii clinical trials using a limited-sampling procedure

Cancer chemotherapy and pharmacology, 1996, Vol.38 (3), p.254-260

1996

Volltextzugriff (PDF)

Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients

Pharmaceutical research, 1996-05, Vol.13 (5), p.794-797

1996

Volltextzugriff (PDF)

Lead levels on traffic-less islands

Journal of epidemiology and community health (1979), 1985-09, Vol.39 (3), p.256-258

1985

Volltextzugriff (PDF)

The genetic architecture of multiple myeloma

Nature reviews. Cancer, 2012-05, Vol.12 (5), p.335

2012

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(229)

Publikationsform

Artikel
(274)

Sprache

Englisch
(274)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study

Exploring cell tropism as a possible contributor to influenza infection severity

Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir

Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B-Cell Levels Do Not Correlate With Clinical Response

Absence of Adverse Effects of Oseltamivir on Sleep: A Double‐Blind, Randomized Study in Healthy Volunteers in Japan

A PBPK model describing a xenobiotic with a short PK event scale

Effect of Impaired Renal Function on the Pharmacokinetics of Tomopenem (RO4908463/CS-023), a Novel Carbapenem

Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-β1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants

Effect of oseltamivir treatment on anticoagulation: a cross‐over study in warfarinized patients

Protective values for soil lead with respect to child health: a critique of UK guidelines

Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

Lack of age and gender effects on single‐dose pharmacokinetics of tomopenem (RO4908463/CS‐023), a novel carbapenem

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency

Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment

Evaluation of water quality of the Qaraaoun Reservoir, Lebanon: Suitability for multipurpose usage

Pharmacokinetics and Safety of Gadobenate Dimeglumine (Multihance) in Subjects With Impaired Liver Function

Effect of R667, a Novel Emphysema Agent, on the Pharmacokinetics of Midazolam in Healthy Men

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks

Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase ii clinical trials using a limited-sampling procedure

Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients

Lead levels on traffic-less islands

The genetic architecture of multiple myeloma

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Aktive Filter

Suchergebnisse filtern